查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602183

组织诊断市场：按产品、技术、适应症和最终用户划分 - 全球预测 2025-2030

Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年组织诊断市场价值为83亿美元，预计到2024年将达到89.4亿美元，复合年增长率为7.76%，到2030年将达到140.2亿美元。

组织诊断市场包括在细胞层面分析和检测疾病的工具和技术，主要用于癌症诊断领域，但也用于感染疾病和组织病理学研究等其他领域，并且也在不断扩大。组织诊断在精准医疗中的重要角色凸显了对组织诊断的需求，可以根据个别患者的病理情况制定客製化的治疗方法。应用包括但不限于免疫组织化学、原位杂合反应、数位病理学和特殊染色，这些是医院、实验室和诊断诊所的重要最终用途。组织诊断市场的成长是由癌症盛行率增加、生物标记研究的进步以及诊断技术的创新等因素所推动的。一个值得注意的机会在于数位病理学和人工智慧主导分析的集成，以提高诊断准确性和工作流程效率。这可能有助于解决技能短缺和快速诊断需求增加等挑战。然而，由于先进诊断工具和基础设施的高成本、监管障碍以及某些地区缺乏熟练人才等限制，采用率放缓。此外，储存和分析组织样本固有的复杂性可能会带来操作挑战。具有巨大潜力的研发领域包括开发用于就地检验的可携式、经济高效的诊断试剂套件，以及进一步完善用于病理学预测分析的人工智慧演算法。该市场的特点是竞争格局，主要企业结盟并进行合併，以扩大产品系列和区域影响力。消费者对个人化医疗解决方案的需求以及对医疗基础设施投资的增加，尤其是在新兴国家，预计将提供巨大的市场机会。企业应专注于与科技公司和研究机构的策略联盟，以利用创新解决方案来解决现有的限制。

主要市场统计
基准年[2023] 83亿美元
预测年份 [2024] 89.4亿美元
预测年份 [2030] 140.2亿美元
复合年增长率（%） 7.76%

市场动态：快速发展的组织诊断市场的关键市场洞察

供需的动态交互作用正在改变组织诊断市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球癌症发生率增加
    • 扩大个人化医疗的使用
    • 政府努力提高人们对有效早期癌症诊断的认识
  • 市场限制因素
    • 组织诊断的高成本和报销问题
  • 市场机会
    • 开始数位病理学和自动化组织诊断
    • 组织诊断领域创新技术与设备开发
  • 市场挑战
    • 与组织诊断技术相关的限制和隐私问题

波特五力：驾驭组织诊断市场的策略工具

波特的五力架构是了解组织诊断市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解组织诊断市场的外部影响

外部宏观环境因素在塑造组织诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解组织诊断市场的竞争状况

组织诊断市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵组织诊断市场供应商的绩效评估

FPNV定位矩阵是评估组织诊断市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症发生率增加
      • 扩大个人化医疗的使用
      • 政府努力提高人们对有效早期癌症诊断的认识
    • 抑制因素
      • 组织诊断的高成本和报销问题
    • 机会
      • 数位病理学和自动化的开始 组织诊断药物
      • 组织诊断领域创新技术与设备开发
    • 任务
      • 与组织诊断程序相关的限制和隐私问题
  • 市场区隔分析
    • 产品：组织处理系统的普及，用于诊断组织样本的高效处理和分析
    • 技术：采用数位病理技术，透过电脑技术对数位化组织学样本进行管理
    • 适应症：组织诊断在多种癌症类型的检测和表征中的指数级应用
    • 最终用户：临床病理实验室更多地利用组织诊断来提高患者照护质量
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章组织诊断市场：副产品

  • 配件
  • 消耗品
    • 抗体
    • 套件
    • 探测
    • 试剂
  • 装置
    • 扫描器
    • 玻片染色系统
    • 组织微阵列
    • 组织处理系统
  • 软体

第七章组织诊断市场：依技术分类

  • 数位病理学和工作流程
  • 免疫组织化学
  • 原位杂交
  • 特殊染色

第八章按适应症分類的组织学诊断市场

  • 乳癌
  • 胃癌
  • 淋巴瘤
  • 非小细胞肺癌
  • 摄护腺癌

第九章组织诊断市场：依最终使用者分类

  • 临床病理学
  • 合约调查机构
  • 医院
  • 製药机构
  • 研究室

第十章北美和南美组织诊断药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太组织诊断市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章：欧洲、中东和非洲的组织诊断市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • PathAI 宣布扩建生物製药实验室，提供端对端中央病理学和组织学服务
    • Ibex 筹集了 5500 万美元的 C 系列资金筹措，以推进癌症诊断领域的人工智慧世界
    • Quest Diagnostics 推出新的前列腺癌检测以改善诊断和分级
    • Cythelabs 将诊断服务扩展到印度南部的医院和患者
    • Biotechne 收购 Lunaphor 以透过空间生物学加强癌症诊断
    • Lunaphore 获得 4000 万瑞士法郎以加强组织诊断解决方案组合
    • 推出免疫组织化学新试剂解决方案“Optimer-Fc”
    • Ibex 和 Albano Laboratories 签署癌症诊断人工智慧的多年、多组织扩展协议
    • 罗氏扩大与杨森的合作关係，透过伴同性诊断推动个人化医疗保健
    • Guardant Health 将 Lunit 基于 AI 的 Pd-L1 评分演算法整合到产品组合中，以增强癌症生物标记检测
    • Epredia 和 Aiforia 加入 RegenMed Hub 创新加速器，伙伴关係扩大了 PHC 集团在再生医学领域的影响力，为新的 RegenMed 临床试验催化剂计划铺平了道路
    • 微软与 Page 合作推动癌症诊断和治疗
    • 安捷伦和 Akoya Biosciences 宣布合作推动生物製药应用多重组织检测开发
    • Tempus 其基于 NGS 的体外诊断设备 xT CDx 获得美国FDA核准
    • 罗氏组织诊断庆祝 Marana 扩建计划

公司名单

  • Abbott Laboratories
  • Abcam Plc
  • Agilent Technologies, Inc.
  • Atlas Antibodies AB
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biogenex Laboratories Inc.
  • BioIVT, LLC
  • bioMerieux SA
  • Cardinal Health, Inc.
  • Castle Biosciences, Inc.
  • Cell Signaling Technology, Inc.
  • Diagnostic BioSystems Inc.
  • F. Hoffmann-La Roche Ltd
  • Leica Biosystems by Danaher Corporation
  • McKesson Corporation
  • Merck KGaA
  • MILESTONE MEDICAL Srl
  • PathAI, Inc.
  • Pfizer Inc.
  • PROGEN Biotechnik GmbH
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers AG
  • SLEE medical GmbH
  • Thermo Fisher Scientific Inc.
Product Code: MRR-03142C0401D5

The Tissue Diagnostics Market was valued at USD 8.30 billion in 2023, expected to reach USD 8.94 billion in 2024, and is projected to grow at a CAGR of 7.76%, to USD 14.02 billion by 2030.

The tissue diagnostics market encompasses tools and technologies used to analyze and detect diseases at the cellular level, primarily in the realm of cancer diagnostics but extending to other areas such as infectious diseases and histopathological studies. The necessity of tissue diagnostics is underscored by its critical role in precision medicine, enabling tailored treatment regimens based on individual patient pathology. Applications include but are not limited to, immunohistochemistry, in situ hybridization, digital pathology, and special staining, which find significant end-use in hospitals, research laboratories, and diagnostic clinics. Growth in the tissue diagnostics market is driven by factors such as the increasing prevalence of cancer, advances in biomarker research, and technological innovations in diagnostic techniques. A notable opportunity lies in the integration of digital pathology and AI-driven analytics to enhance diagnostic accuracy and workflow efficiency. This could help address challenges like skill shortages and the increasing demand for rapid diagnostics. Limitations, however, consist of the high costs of advanced diagnostic tools and infrastructure, regulatory barriers, and a lack of skilled personnel in some regions, slowing adoption rates. Additionally, the inherent complexity of tissue sample preservation and analysis can pose operational challenges. Innovation and research areas with significant potential include the development of portable, cost-effective diagnostic kits for point-of-care testing and the further refinement of AI algorithms for predictive analytics in pathology. The market is characterized by a competitive landscape with ongoing collaborations and mergers among prominent players aiming to expand their product portfolios and geographical reach. Consumer demand for personalized medical solutions and the increasing investment in healthcare infrastructure, particularly in emerging economies, are expected to provide substantial market opportunities. Companies should focus on strategic partnerships with technology firms and research institutions to harness innovative solutions that address existing limitations.

KEY MARKET STATISTICS
Base Year [2023] USD 8.30 billion
Estimated Year [2024] USD 8.94 billion
Forecast Year [2030] USD 14.02 billion
CAGR (%) 7.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Diagnostics Market

The Tissue Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of cancer worldwide
    • Growing use of personalized medicine
    • Government initiatives to increase awareness regarding effective and early cancer diagnosis
  • Market Restraints
    • High cost involved in tissue diagnosis and reimbursement issues
  • Market Opportunities
    • Inception of digital pathology and automated tissue diagnostics
    • Innovative technologies and instruments development in tissue diagnostic field
  • Market Challenges
    • Limitations associated with tissue diagnostics procedures coupled with privacy concerns

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Diagnostics Market

A detailed market share analysis in the Tissue Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Tissue Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Agilent Technologies, Inc., Atlas Antibodies AB, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenex Laboratories Inc., BioIVT, LLC, bioMerieux SA, Cardinal Health, Inc., Castle Biosciences, Inc., Cell Signaling Technology, Inc., Diagnostic BioSystems Inc., F. Hoffmann-La Roche Ltd, Leica Biosystems by Danaher Corporation, McKesson Corporation, Merck KGaA, MILESTONE MEDICAL Srl, PathAI, Inc., Pfizer Inc., PROGEN Biotechnik GmbH, QIAGEN N.V., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens Healthineers AG, SLEE medical GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, Consumables, Instruments, and Software. The Consumables is further studied across Antibodies, Kits, Probes, and Reagents. The Instruments is further studied across Scanners, Slide-staining Systems, Tissue Microarrays, and Tissue-processing Systems.
  • Based on Technology, market is studied across Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.
  • Based on Indications, market is studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.
  • Based on End-User, market is studied across Clinical Pathology, Contract Research Organization, Hospitals, Pharmaceutical Organizations, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cancer worldwide
      • 5.1.1.2. Growing use of personalized medicine
      • 5.1.1.3. Government initiatives to increase awareness regarding effective and early cancer diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Inception of digital pathology and automated tissue diagnostics
      • 5.1.3.2. Innovative technologies and instruments development in tissue diagnostic field
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with tissue diagnostics procedures coupled with privacy concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples
    • 5.2.2. Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology
    • 5.2.3. Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types
    • 5.2.4. End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Consumables
    • 6.3.1. Antibodies
    • 6.3.2. Kits
    • 6.3.3. Probes
    • 6.3.4. Reagents
  • 6.4. Instruments
    • 6.4.1. Scanners
    • 6.4.2. Slide-staining Systems
    • 6.4.3. Tissue Microarrays
    • 6.4.4. Tissue-processing Systems
  • 6.5. Software

7. Tissue Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital Pathology & Workflow
  • 7.3. Immunohistochemistry
  • 7.4. In Situ Hybridization
  • 7.5. Special Staining

8. Tissue Diagnostics Market, by Indications

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Gastric Cancer
  • 8.4. Lymphoma
  • 8.5. Non Small Cell Lung Cancer
  • 8.6. Prostate Cancer

9. Tissue Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinical Pathology
  • 9.3. Contract Research Organization
  • 9.4. Hospitals
  • 9.5. Pharmaceutical Organizations
  • 9.6. Research Laboratories

10. Americas Tissue Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Tissue Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Tissue Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services
    • 13.3.2. Ibex Raises USD 55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis
    • 13.3.3. Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
    • 13.3.4. Cytelabs expanding diagnostic services to hospitals and patients across south India
    • 13.3.5. Bio-Techne Buys Lunaphore to Boost Cancer Diagnostics Through Spatial Biology
    • 13.3.6. Lunaphore Secures Chf 40 Million to Boost Portfolio of Tissue Diagnostics Solutions
    • 13.3.7. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
    • 13.3.8. Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis
    • 13.3.9. Roche Expands Collaboration with Janssen to Advance Personalized Healthcare Through Companion Diagnostics
    • 13.3.10. Guardant Health to Integrate Lunit's Ai-Based Scoring Algorithm for Pd-L1 into its Portfolio to Enhance Cancer Biomarker Detection
    • 13.3.11. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
    • 13.3.12. Microsoft Strikes Partnership with Paige to Advance Cancer Diagnostics and Treatment
    • 13.3.13. Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
    • 13.3.14. Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
    • 13.3.15. ROCHE tissue diagnostics celebrates marana expansion project

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Abcam Plc
  • 3. Agilent Technologies, Inc.
  • 4. Atlas Antibodies AB
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Techne Corporation
  • 7. Biogenex Laboratories Inc.
  • 8. BioIVT, LLC
  • 9. bioMerieux SA
  • 10. Cardinal Health, Inc.
  • 11. Castle Biosciences, Inc.
  • 12. Cell Signaling Technology, Inc.
  • 13. Diagnostic BioSystems Inc.
  • 14. F. Hoffmann-La Roche Ltd
  • 15. Leica Biosystems by Danaher Corporation
  • 16. McKesson Corporation
  • 17. Merck KGaA
  • 18. MILESTONE MEDICAL Srl
  • 19. PathAI, Inc.
  • 20. Pfizer Inc.
  • 21. PROGEN Biotechnik GmbH
  • 22. QIAGEN N.V.
  • 23. Quest Diagnostics Incorporated
  • 24. Sekisui Diagnostics, LLC
  • 25. Siemens Healthineers AG
  • 26. SLEE medical GmbH
  • 27. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. TISSUE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 174. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 186. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 198. ISRAEL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 204. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 210. NETHERLANDS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. NIGERIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. NORWAY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 228. POLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. QATAR TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 246. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 261. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 262. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 264. SWEDEN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 268. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 270. SWITZERLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 273. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 274. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. TURKEY TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 286. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 288. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 289. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 290. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023